Saizen (Somatropin) Injection

Price: $48 per package

Saizen (Somatropin) Injection is a recombinant human growth hormone medicine containing somatropin, a laboratory-produced form of human growth hormone. It is manufactured using recombinant DNA technology and has the same amino-acid sequence as the predominant form of naturally occurring human pituitary growth hormone. Saizen is supplied for administration by subcutaneous injection and should be used only under appropriate medical supervision.

The Saizen brand has been associated with Merck Serono / EMD Serono in different markets. Product presentation, strength, diluent, packaging, and manufacturing location can vary between countries, so customers should always check the information printed on the supplied package rather than relying on a general product description alone.

Saizen Somatropin Product Details

• Brand: Saizen
• Active ingredient: Somatropin
• Medicine type: Recombinant human growth hormone
• Route of administration: Subcutaneous injection
• Dosage form: Injection / powder for solution for injection, depending on presentation
• Manufacturer/brand company: Merck Serono / EMD Serono
• Price: $48 per package
• Package quantity: Check the selected product presentation
• Prescription status: Prescription medicine

Saizen contains somatropin produced through recombinant DNA technology. Growth hormone has important effects on normal growth and metabolism, including the body’s handling of proteins, carbohydrates, and fats. Because treatment requirements differ considerably between patients, Saizen is not a product for which a universal dose or injection schedule should be recommended on a retail product page.

What Is Saizen Used For?

Saizen has been used medically for the treatment of growth hormone deficiency (GHD). Approved indications depend on the country and current product authorization. U.S. prescribing information has included treatment of children with growth failure caused by inadequate secretion of endogenous growth hormone and treatment of adults with childhood-onset or adult-onset growth hormone deficiency.

A healthcare professional should establish the diagnosis before treatment and determine whether somatropin is appropriate. Dose selection may depend on factors such as age, body weight, clinical response, laboratory measurements, and the condition being treated.

Saizen should not be promoted as an ordinary fitness, bodybuilding, weight-loss, or cosmetic product. Use outside approved medical indications can involve significant health risks and should not be presented as an expected benefit of the medicine.

Administration and Handling

Saizen is intended for subcutaneous administration. Certain presentations may require reconstitution before injection, while the exact preparation method depends on the strength and device supplied with the medicine.

Patients or caregivers should receive proper instruction from a qualified healthcare professional before preparing or injecting Saizen. Injection sites may need to be rotated according to professional guidance to help reduce local tissue problems. Needles, syringes, or other single-use injection components should not be shared.

Always follow the instructions supplied with the exact Saizen presentation you receive. Do not use the medicine if the solution or packaging does not match the manufacturer’s instructions for appearance and integrity.

Storage Information

Correct storage is important because somatropin is a protein-based medicine that can be affected by unsuitable temperatures and handling. Storage requirements can differ between Saizen presentations and between unopened and reconstituted products.

Keep the product under the temperature conditions stated on its original carton and patient information leaflet. Protect it from inappropriate heat, freezing, and unnecessary exposure to light. Do not use Saizen after the printed expiry date or if storage conditions have not been maintained.

Important Safety Information

Somatropin treatment is not suitable for every patient. Prescribing information lists important contraindications and precautions, including certain cases involving active malignancy, acute critical illness, severe diabetic retinopathy, and closed epiphyses in children.

Growth hormone treatment may also require monitoring for effects involving glucose metabolism, thyroid function, fluid retention, intracranial pressure, and other medical conditions. Report persistent headache, visual changes, swelling, severe joint or muscle symptoms, unusual reactions, or other concerning effects to a healthcare professional.

Patients using diabetes medicines, corticosteroids, hormone treatments, or other prescription medicines should make their healthcare provider aware of them because treatment adjustments or additional monitoring may be required.

Package Verification

Before use, check the Saizen name, somatropin strength, expiry date, batch information, manufacturer details, package integrity, and storage requirements printed on the supplied product. Because Saizen presentations differ by market, the physical package and official accompanying leaflet should be treated as the primary reference for the exact strength and preparation instructions.

Saizen (Somatropin) Injection is a prescription growth hormone medicine and should be used only when prescribed and monitored by an appropriately qualified healthcare professional.